Wave Life Sciences Ltd.

WVE · Nasdaq · SIC 2834: Pharmaceutical Preparations
242
SEC Filings

Business Summary

PART I Overview We are a clinical-stage biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines (also known as oligonucleotides), or those targeting RNA, to transform human health. Our RNA medicines platform, PRISM , combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Our toolkit of RNA-targeting modalities, including RNAi (SpiNA) and RNA ...

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionWVEdiscussed_in_filing Cybersecurity
topic_mentionWVEdiscussed_in_filing Cybersecurity
topic_mentionWVEdiscussed_in_filing Platform & Ecosystem
topic_mentionWVEdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-073472EDGAR97K words
2025-03-042024-12-310000950170-25-031322EDGAR—
2024-03-062023-12-310000950170-24-026876EDGAR—
2023-03-232022-12-310000950170-23-009319EDGAR—
2022-03-032021-12-310001564590-22-008414EDGAR—
2021-03-042020-12-310001564590-21-010718EDGAR—
2020-03-022019-12-310001564590-20-007972EDGAR—
2019-03-012018-12-310001564590-19-005671EDGAR—
2018-03-122017-12-310001564590-18-005308EDGAR—
2017-03-162016-12-310001564590-17-004649EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-273288EDGAR23K words
2025-07-302025-06-300000950170-25-099884EDGAR—
2025-05-082025-03-310000950170-25-066404EDGAR—
2024-11-122024-09-300000950170-24-124595EDGAR—
2024-08-082024-06-300000950170-24-093341EDGAR—
2024-05-102024-03-310000950170-24-057457EDGAR—
2023-11-092023-09-300000950170-23-061544EDGAR—
2023-08-032023-06-300000950170-23-037601EDGAR—
2023-05-032023-03-310000950170-23-016888EDGAR—
2022-11-102022-09-300000950170-22-024171EDGAR—
2022-08-112022-06-300000950170-22-016653EDGAR—
2022-05-122022-03-310000950170-22-009469EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-125092EDGAR2K words
2026-02-260001193125-26-073437EDGAR—
2026-02-020001193125-26-032698EDGAR—
2026-01-120001193125-26-009784EDGAR—
2025-12-110001193125-25-314746EDGAR—
2025-12-080001193125-25-310595EDGAR—
2025-11-170001193125-25-283929EDGAR—
2025-11-100001193125-25-273278EDGAR—
2025-10-290001193125-25-256682EDGAR—
2025-09-240001193125-25-214176EDGAR—

242 total filings indexed. 210 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001631574
TickerWVE
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedU0

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1ce42065502bff855011ddf011aa6300ee6bb87e73b2a8a86340f00998dffebb
parent: 6b0427f94d33015da7b2b440527a95050db393b50d9a7f217d684e24a0d797da
content hash: 19f5878739dd271469e02099d8eb3bd18fc8a625aa13ee2eb020f8b4c50832c1
signed: 2026-04-13T04:48:16.731Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf